1-Amido-1-phenyl-3-piperidinylbutanes – CCR5 antagonists for the treatment of HIV: Part 2
摘要:
Optimisation of a series of 4-piperidinyltriazoles led to the identification of compound 28a which showed good whole cell antiviral activity, excellent selectivity over the hERG ion channel and complete oral absorption. (C) 2009 Elsevier Ltd. All rights reserved.
1-Amido-1-phenyl-3-piperidinylbutanes – CCR5 antagonists for the treatment of HIV: Part 2
摘要:
Optimisation of a series of 4-piperidinyltriazoles led to the identification of compound 28a which showed good whole cell antiviral activity, excellent selectivity over the hERG ion channel and complete oral absorption. (C) 2009 Elsevier Ltd. All rights reserved.
[EN] TRIAZOLYLPIPERIDINE DERIVATIVES AND USE THEREOF IN THERAPY<br/>[FR] DERIVES DE TRIAZOLYLPIPERIDINE ET LEUR UTILISATION A DES FINS THERAPEUTIQUES
申请人:PFIZER LTD
公开号:WO2006136917A1
公开(公告)日:2006-12-28
[EN] The present invention provides compounds of formula (I) Wherein R1 , R2, R3 , R4 , Het and m are as defined in the description. The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. [FR] La présente invention concerne des composés de formule (I), dans laquelle R1, R2, R3, R4, Het et m sont tels que définis dans la description. Les composés de la présente invention sont des modulateurs, et notamment des antagonistes, de l'activité des récepteurs de chimiokine CCR5.
1-Amido-1-phenyl-3-piperidinylbutanes – CCR5 antagonists for the treatment of HIV: Part 2
作者:Christopher G. Barber、David C. Blakemore、Jean-Yves Chiva、Rachel L. Eastwood、Donald S. Middleton、Kerry A. Paradowski
DOI:10.1016/j.bmcl.2009.01.008
日期:2009.3
Optimisation of a series of 4-piperidinyltriazoles led to the identification of compound 28a which showed good whole cell antiviral activity, excellent selectivity over the hERG ion channel and complete oral absorption. (C) 2009 Elsevier Ltd. All rights reserved.